Trexquant Investment’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.8M | Buy |
547,076
+532,685
| +3,702% | +$43.9M | 0.31% | 46 |
|
|
2025
Q4 | $1.23M | Sell |
14,391
-104,986
| -88% | -$8.62M | 0.01% | 1122 |
|
|
2025
Q3 | $9.28M | Buy |
119,377
+58,787
| +97% | +$4.59M | 0.1% | 318 |
|
|
2025
Q2 | $4.74M | Buy |
60,590
+26,482
| +78% | +$1.98M | 0.05% | 548 |
|
|
2025
Q1 | $2.47M | Buy |
+34,108
| New | +$2.44M | 0.03% | 791 |
|
|
2024
Q4 | – | Sell |
-440,206
| Closed | -$29M | – | 1638 |
|
|
2024
Q3 | $29M | Buy |
+440,206
| New | +$32M | 0.37% | 27 |
|
|
2024
Q1 | – | Sell |
-101,129
| Closed | -$7.71M | – | 1519 |
|
|
2023
Q4 | $7.71M | Sell |
101,129
-40,660
| -29% | -$2.83M | 0.17% | 147 |
|
|
2023
Q3 | $9.82M | Buy |
141,789
+69,809
| +97% | +$5.61M | 0.25% | 86 |
|
|
2023
Q2 | $6.79M | Buy |
71,980
+14,664
| +26% | +$1.27M | 0.18% | 141 |
|
|
2023
Q1 | $4.74M | Buy |
+57,316
| New | +$4.51M | 0.13% | 205 |
|
|
2022
Q4 | – | Sell |
-99,935
| Closed | -$8.26M | – | 1466 |
|
|
2022
Q3 | $8.26M | Buy |
99,935
+84,623
| +553% | +$8.14M | 0.29% | 80 |
|
|
2022
Q2 | $1.46M | Sell |
15,312
-3,168
| -17% | -$328K | 0.07% | 362 |
|
|
2022
Q1 | $2.17M | Buy |
18,480
+4,336
| +31% | +$486K | 0.1% | 249 |
|
|
2021
Q4 | $1.83M | Sell |
14,144
-40,482
| -74% | -$4.72M | 0.11% | 231 |
|
|
2021
Q3 | $6.18M | Buy |
54,626
+17,541
| +47% | +$2M | 0.49% | 34 |
|
|
2021
Q2 | $3.84M | Buy |
37,085
+14,356
| +63% | +$1.35M | 0.32% | 71 |
|
|
2021
Q1 | $1.9M | Buy |
+22,729
| New | +$1.92M | 0.17% | 152 |
|
|
2020
Q4 | – | Sell |
-8,872
| Closed | -$708K | – | 1152 |
|
|
2020
Q3 | $708K | Sell |
8,872
-5,943
| -40% | -$464K | 0.05% | 539 |
|
|
2020
Q2 | $1.02M | Sell |
14,815
-72,668
| -83% | -$5.16M | 0.07% | 390 |
|
|
2020
Q1 | $5.5M | Sell |
87,483
-75,690
| -46% | -$5.46M | 0.4% | 32 |
|
|
2019
Q4 | $12.7M | Buy |
+163,173
| New | +$12.7M | 0.75% | 9 |
|
|
2019
Q3 | – | Sell |
-11,091
| Closed | -$683K | – | 930 |
|
|
2019
Q2 | $683K | Buy |
+11,091
| New | +$671K | 0.06% | 403 |
|
|
2019
Q1 | – | Sell |
-111,762
| Closed | -$5.71M | – | 1078 |
|
|
2018
Q4 | $5.71M | Buy |
111,762
+106,815
| +2,159% | +$5.4M | 0.36% | 55 |
|
|
2018
Q3 | $287K | Sell |
4,947
-50,091
| -91% | -$2.45M | 0.02% | 699 |
|
|
2018
Q2 | $2.67M | Sell |
55,038
-65,943
| -55% | -$3.08M | 0.19% | 182 |
|
|
2018
Q1 | $5.63M | Buy |
120,981
+75,150
| +164% | +$3.26M | 0.39% | 28 |
|
|
2017
Q4 | $1.72M | Buy |
45,831
+7,065
| +18% | +$259K | 0.19% | 150 |
|
|
2017
Q3 | $1.41M | Buy |
+38,766
| New | +$1.48M | 0.36% | 47 |
|
|
2016
Q3 | – | Sell |
-97,500
| Closed | -$3.24M | – | 797 |
|
|
2016
Q2 | $3.24M | Buy |
97,500
+57,000
| +141% | +$1.95M | 0.43% | 37 |
|
|
2016
Q1 | $1.19M | Buy |
40,500
+26,328
| +186% | +$726K | 0.14% | 238 |
|
|
2015
Q4 | $373K | Sell |
14,172
-56,820
| -80% | -$1.48M | 0.03% | 780 |
|
|
2015
Q3 | $1.68M | Buy |
+70,992
| New | +$1.71M | 0.14% | 211 |
|
|
2015
Q1 | – | Sell |
-35,400
| Closed | -$751K | – | 1034 |
|
|
2014
Q4 | $751K | Buy |
+35,400
| New | +$711K | 0.13% | 278 |
|
Other funds holding EW
VCM
VPM
Trexquant Investment's EW Position: Q1 2026 in Review
Trexquant Investment increased its Edwards Lifesciences (EW) stake by 3,702% in Q1 2026, buying an estimated $43.9M and bringing the position to 547,076 shares worth $43.8M. The position accounts for 0.31% of the portfolio, ranked #46.
Trexquant Investment first reported a position in EW in Q4 2014 and has held it in 33 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Trexquant Investment held 547,076 shares of Edwards Lifesciences worth $43.8M as of Q1 2026.
- Trexquant Investment bought 532,685 Edwards Lifesciences shares in Q1 2026, an estimated $43.9M.
- Edwards Lifesciences made up 0.31% of Trexquant Investment's portfolio in Q1 2026, its #46 holding.
- Trexquant Investment first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 33 quarters since.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.